chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: I got little sick but this one is bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Mar2021 (Lot number: EN6198) at the age of 51 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Lupus" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing). Concomitant medication(s) included: ZOLOFT; KLONOPIN; TOPAMAX. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I got little sick but this one is bad".  Additional information: Reaction/event as reported by primary source : she got little sick but this one was bad. Consumer stated, "Okay, she really did not know where to start so, may be we jump in and ask questions that will be great because she was not feeling well. Okay, so on 1Apr she had her second Covid vaccination Pfizer one, her first one she got little sick but this one was bad and she had a partner that she was living with and she and patient have been together for 25 years and both got their shots on the same days and she was in the shape reporter was in, which was not good. When requested for probing, Consumer stated, she also had Lupus so she was in autoimmune lupus and prone disease and all kind of stuff though. When probed for as she was suffering from any other medical condition, consumer stated, "It had been since she received her first shot; you mean high blood pressure." (Further not clarified hence not captured in tab).   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nervousness
Clinical narrative: He is nervous about taking the second shot; He got dizzy when he went to go bed; every time he moved his head throughout the night he would wake up feeling dizzy.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NERVOUSNESS (non-serious), outcome "unknown", described as "He is nervous about taking the second shot"; DIZZINESS (non-serious), outcome "unknown", described as "He got dizzy when he went to go bed; every time he moved his head throughout the night he would wake up feeling dizzy.".  Additional information: Reporter stated, "He got dizzy when he went to go bed, as soon as he laid his head on pillow and then throughout the night, every time he moved his head throughout the night he would wake up feeling dizzy. We are wondering when it's going to get better because he is nervous about taking the second shot."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Oropharyngeal discomfort, Oxygen saturation
Clinical narrative: Throat "tickling" clearing; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A 37 year-old male patient received bnt162b2 (BNT162B2), administration date 08Apr2021 11:45 (Lot number: EP7533) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1, Product: COVID 19, Lot unknown: False, Differential Diagnosis: Anaphylaxis (dyspnea, stridor, drooling, tongue swelling), 11:30 Vitals: BP 138/89, HR 81, O2 96%.), for COVID-19 Immunization, reaction(s): "Drooling", "Dyspnea", "Stridor", "Tongue swelling"; Bnt162b2 (Dose number: 1, Product: COVID 19, Lot unknown: False, During his 30 minute waiting period after the injection, the patient began to experience throat tightness and tongue swelling., 11:30 Vitals: BP 138/89, HR 81, O2 96%.), for COVID-19 Immunization, reaction(s): "Tongue swelling", "Throat tightness"; Bnt162b2 (Dose number: 1, Product: COVID 19, Lot unknown: False, 1st Pfizer vaccine patient had facial/throat swelling after the 15 min waiting period while driving home. No medical treatment, self resolved with Benadryl at home., 11:30 Vitals: BP 138/89, HR 81, O2 96%.), for COVID-19 Immunization, reaction(s): "Facial/throat swelling", "Facial/throat swelling". The following information was reported: OROPHARYNGEAL DISCOMFORT (non-serious) with onset 08Apr2021 12:00, outcome "unknown", described as "Throat "tickling" clearing". The patient underwent the following laboratory tests and procedures: blood pressure measurement: (08Apr2021) 141/89; heart rate: (08Apr2021) 68; oxygen saturation: (08Apr2021) 97 %.  Additional information: Lung sounds clear, no visible swelling.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: she was in a lot of pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program support. The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administration date 19Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "chrons disease" (unspecified if ongoing), notes: for several years now and is disabled, prior to getting any shot; "bad back" (unspecified if ongoing), notes: for several years now and is disabled, prior to getting any shot. The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "she was in a lot of pain". Therapeutic measures were taken as a result of pain.  Additional information: Patient second shot was scheduled for 09Apr2021. She had a steroid shot pre-scheduled for two weeks after her first dosage and has already taken that steroid shot now for the reported event. Patient was asking will this affect the efficacy of vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Malaise, Pain, Tongue disorder
Clinical narrative: swelling on the injection site (left side); pain from head to toe on the side; dizziness; weakness; not feeling well; tongue became heavy and then dry; tongue became heavy and then dry; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 49 year-old female patient received bnt162b2 (BNT162B2), administration date 09Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset Apr2021, outcome "unknown", described as "swelling on the injection site (left side)"; PAIN (non-serious) with onset Apr2021, outcome "unknown", described as "pain from head to toe on the side"; DIZZINESS (non-serious) with onset Apr2021, outcome "unknown", described as "dizziness"; ASTHENIA (non-serious) with onset Apr2021, outcome "unknown", described as "weakness"; MALAISE (non-serious) with onset Apr2021, outcome "unknown", described as "not feeling well"; TONGUE DISORDER (non-serious), TONGUE DRY (non-serious) all with onset Apr2021, outcome "unknown" and all described as "tongue became heavy and then dry".  Additional information: Patient took Pfizer 1st shot on 09Apr. Noticed swelling on the injection site (left side) and have pain from head to toe on the side. Also had dizziness, weakness and not feeling well. Also mentioned her tongue became heavy and then dry before experiencing the other symptoms. Asked what to do.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Tongue dry, Vaccination site swelling
Clinical narrative: swelling on the injection site (left side); pain from head to toe on the side; dizziness; weakness; not feeling well; tongue became heavy and then dry; tongue became heavy and then dry; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 49 year-old female patient received bnt162b2 (BNT162B2), administration date 09Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset Apr2021, outcome "unknown", described as "swelling on the injection site (left side)"; PAIN (non-serious) with onset Apr2021, outcome "unknown", described as "pain from head to toe on the side"; DIZZINESS (non-serious) with onset Apr2021, outcome "unknown", described as "dizziness"; ASTHENIA (non-serious) with onset Apr2021, outcome "unknown", described as "weakness"; MALAISE (non-serious) with onset Apr2021, outcome "unknown", described as "not feeling well"; TONGUE DISORDER (non-serious), TONGUE DRY (non-serious) all with onset Apr2021, outcome "unknown" and all described as "tongue became heavy and then dry".  Additional information: Patient took Pfizer 1st shot on 09Apr. Noticed swelling on the injection site (left side) and have pain from head to toe on the side. Also had dizziness, weakness and not feeling well. Also mentioned her tongue became heavy and then dry before experiencing the other symptoms. Asked what to do.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Insomnia, Myalgia
Clinical narrative: muscle aches; Diarrhea; Headache; She experienced insomnia since she had the 2nd dose of the vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 (Lot number: ER8733) at the age of 66 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose, EN6198, LEFT arm), administration date: 15Mar2021, when the patient was 66 years old, for COVID-19 immunization. The following information was reported: INSOMNIA (non-serious) with onset 05Apr2021, outcome "not recovered", described as "She experienced insomnia since she had the 2nd dose of the vaccine"; MYALGIA (non-serious) with onset 06Apr2021, outcome "not recovered", described as "muscle aches"; DIARRHOEA (non-serious) with onset 06Apr2021, outcome "recovering", described as "Diarrhea"; HEADACHE (non-serious) with onset 06Apr2021, outcome "not recovered", described as "Headache". Therapeutic measures were taken as a result of insomnia.  Additional information: She had very bad insomnia since the second dose of vaccine. Patient's stated that last week was really horrible and then she had diarrhea and a headache and muscle aches and had been taking melatonin to help with the insomnia, does not like doing it because she does not like drowsiness.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph node under armpit is enlarged; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from a Pfizer sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (patient has tested positive for COVID-19 previously). The patient's concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph node under armpit is enlarged".  Clinical course: Four days after receiving 1st vaccine dose, patient's lymph node under armpit was enlarged.  No follow-up attempts are possible. Information on the lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity
Clinical narrative: Chills; tiredness/fatigue; pain in his right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose, Anatomical location: Right Arm), for COVID-19 IMMUNISATION. The following information was reported: CHILLS (non-serious) with onset 08Apr2021, outcome "unknown", described as "Chills"; FATIGUE (non-serious) with onset 08Apr2021, outcome "unknown", described as "tiredness/fatigue"; PAIN IN EXTREMITY (non-serious) with onset 07Apr2021, outcome "unknown", described as "pain in his right arm".  Additional information: On 08Apr that when he received his second shot in his left arm, he felt a pain in his right arm where the first shot had been given.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea
Clinical narrative: "light bowels, almost watery" She says it's like diarrhea.; "stomach feels crampy"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administration date 02Apr2021 (Batch/Lot number: unknown) at the age of 62 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as ""light bowels, almost watery" She says it's like diarrhea."; ABDOMINAL PAIN (non-serious), outcome "unknown", described as ""stomach feels crampy"".  Additional Information: For the past week, she's been experiencing "light bowels, almost watery". She says it's like diarrhea. It's now been almost 1 week. She also mentioned her "stomach feels crampy".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Bedridden, Dizziness
Clinical narrative: I have been on the couch since the 21st of March; Since I got the shot, 2 days after I have been dizzy; It is very difficult to stay balanced; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 79 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 79 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 immunization, reaction(s): "No adverse effect". The following information was reported: DIZZINESS (non-serious) with onset Mar2021, outcome "unknown", described as "Since I got the shot, 2 days after I have been dizzy"; BALANCE DISORDER (non-serious) with onset Mar2021, outcome "unknown", described as "It is very difficult to stay balanced"; BEDRIDDEN (non-serious) with onset 21Mar2021, outcome "unknown", described as "I have been on the couch since the 21st of March".  Additional Information: She had problem with and wanting to know if anyone else reported side effects from the vaccine. She had a lot of trouble and already filed a report. she just finished with my neurologist. Since  got the shot, 2 days after she has been dizzy. Not spinning but she cant drive, and she cant tell how far the car is from me. It is very difficult to stay balanced. She has been on the couch since the 21st of March. This was my second dose, the first dose she had no problems at all. It's been 20 days since my vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pain, Pain in extremity
Clinical narrative: achy; tired; sore arm; it takes her system longer to recover from things; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "achy"; FATIGUE (non-serious), outcome "unknown", described as "tired"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; MALAISE (non-serious), outcome "unknown", described as "it takes her system longer to recover from things".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: minor sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "minor sore throat".  Additional information: Reporter states that he has a general question.  He already had his first dose of the Covid vaccine and he needs to get his second dose today.  Reporter has a minor sore throat, and wants to know if it is okay to get the second dose. Minor sore throat: caller adds that the sore throat has just been for the last day, there are no other symptoms.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pain in extremity
Clinical narrative: soreness and warmth on her arm; soreness and warmth on her arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "multiple sclerosis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), FEELING HOT (non-serious), outcome "unknown" and all described as "soreness and warmth on her arm".  Additional Information: Patient had multiple sclerosis prior to the vaccine.-Stents put in November. She enquired that would there be any particular side effects she should be concerned about with the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: developed a UTI; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 60 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: URINARY TRACT INFECTION (non-serious), outcome "unknown", described as "developed a UTI".  Additional Information: Patient was due to receive second dose of the Pfizer BioNTech Covid 19 vaccine tomorrow but developed a UTI over the weekend and was prescribed antibiotics.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: severe vertigo after the first dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 81 years as single dose for covid-19 immunisation. Relevant medical history included: "arm swelled up" (unspecified if ongoing), notes: I've had flu shot, a little reaction with the adult one my arm swelled up twice the size for about a week. That was 2 to 3 years ago, the adult stronger one. The patient's concomitant medications were not reported. Vaccination history included: Flu shot, for immunisation, reaction(s): "arm swelled up twice the size ". The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "severe vertigo after the first dose".  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Blood test, Dizziness, Ear pain, Electrocardiogram
Clinical narrative: severe vertigo after the first dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 81 years as single dose for covid-19 immunisation. Relevant medical history included: "arm swelled up" (unspecified if ongoing), notes: I've had flu shot, a little reaction with the adult one my arm swelled up twice the size for about a week. That was 2 to 3 years ago, the adult stronger one. The patient's concomitant medications were not reported. Vaccination history included: Flu shot, for immunisation, reaction(s): "arm swelled up twice the size ". The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "severe vertigo after the first dose".  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertension, Magnetic resonance imaging, Nausea, Ultrasound Doppler, Vertigo
Clinical narrative: severe vertigo after the first dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 81 years as single dose for covid-19 immunisation. Relevant medical history included: "arm swelled up" (unspecified if ongoing), notes: I've had flu shot, a little reaction with the adult one my arm swelled up twice the size for about a week. That was 2 to 3 years ago, the adult stronger one. The patient's concomitant medications were not reported. Vaccination history included: Flu shot, for immunisation, reaction(s): "arm swelled up twice the size ". The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "severe vertigo after the first dose".  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Balance test, Blood pressure measurement, Blood test, Circumstance or information capable of leading to medication error
Clinical narrative: severe vertigo after the first dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 81 years as single dose for covid-19 immunisation. Relevant medical history included: "arm swelled up" (unspecified if ongoing), notes: I've had flu shot, a little reaction with the adult one my arm swelled up twice the size for about a week. That was 2 to 3 years ago, the adult stronger one. The patient's concomitant medications were not reported. Vaccination history included: Flu shot, for immunisation, reaction(s): "arm swelled up twice the size ". The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "severe vertigo after the first dose".  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Ear pain, Electrocardiogram, Hypertension, Magnetic resonance imaging
Clinical narrative: severe vertigo after the first dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 81 years as single dose for covid-19 immunisation. Relevant medical history included: "arm swelled up" (unspecified if ongoing), notes: I've had flu shot, a little reaction with the adult one my arm swelled up twice the size for about a week. That was 2 to 3 years ago, the adult stronger one. The patient's concomitant medications were not reported. Vaccination history included: Flu shot, for immunisation, reaction(s): "arm swelled up twice the size ". The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "severe vertigo after the first dose".  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Ultrasound Doppler, Ultrasound scan, Vertigo
Clinical narrative: severe vertigo after the first dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 81 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) at the age of 81 years as single dose for covid-19 immunisation. Relevant medical history included: "arm swelled up" (unspecified if ongoing), notes: I've had flu shot, a little reaction with the adult one my arm swelled up twice the size for about a week. That was 2 to 3 years ago, the adult stronger one. The patient's concomitant medications were not reported. Vaccination history included: Flu shot, for immunisation, reaction(s): "arm swelled up twice the size ". The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "severe vertigo after the first dose".  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: blood pressure went sky high; Dizziness; extreme vertigo; Nausea; Unsteadiness; Slight ear ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 (Lot number: EN6203) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "thyroid problem" (unspecified if ongoing), notes: Verbatim: thyroid problem; "lyme disease", start date: 2006 (unspecified if ongoing); "spinal tap" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Rocephin, reaction(s): "very high fever", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date.; Rocephin, reaction(s): "rash all over her body", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date. The following information was reported: DIZZINESS (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Dizziness"; VERTIGO (non-serious) with onset 19Mar2021, outcome "not recovered", described as "extreme vertigo"; NAUSEA (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Nausea"; BALANCE DISORDER (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Unsteadiness"; EAR PAIN (non-serious) with onset 19Mar2021, outcome "unknown", described as "Slight ear ache"; HYPERTENSION (non-serious), outcome "unknown", described as "blood pressure went sky high". The events "slight ear ache" and "blood pressure went sky high" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Blood test, Dizziness, Ear pain, Electrocardiogram
Clinical narrative: blood pressure went sky high; Dizziness; extreme vertigo; Nausea; Unsteadiness; Slight ear ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 (Lot number: EN6203) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "thyroid problem" (unspecified if ongoing), notes: Verbatim: thyroid problem; "lyme disease", start date: 2006 (unspecified if ongoing); "spinal tap" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Rocephin, reaction(s): "very high fever", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date.; Rocephin, reaction(s): "rash all over her body", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date. The following information was reported: DIZZINESS (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Dizziness"; VERTIGO (non-serious) with onset 19Mar2021, outcome "not recovered", described as "extreme vertigo"; NAUSEA (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Nausea"; BALANCE DISORDER (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Unsteadiness"; EAR PAIN (non-serious) with onset 19Mar2021, outcome "unknown", described as "Slight ear ache"; HYPERTENSION (non-serious), outcome "unknown", described as "blood pressure went sky high". The events "slight ear ache" and "blood pressure went sky high" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertension, Magnetic resonance imaging, Nausea, Ultrasound Doppler, Vertigo
Clinical narrative: blood pressure went sky high; Dizziness; extreme vertigo; Nausea; Unsteadiness; Slight ear ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 (Lot number: EN6203) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "thyroid problem" (unspecified if ongoing), notes: Verbatim: thyroid problem; "lyme disease", start date: 2006 (unspecified if ongoing); "spinal tap" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Rocephin, reaction(s): "very high fever", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date.; Rocephin, reaction(s): "rash all over her body", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date. The following information was reported: DIZZINESS (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Dizziness"; VERTIGO (non-serious) with onset 19Mar2021, outcome "not recovered", described as "extreme vertigo"; NAUSEA (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Nausea"; BALANCE DISORDER (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Unsteadiness"; EAR PAIN (non-serious) with onset 19Mar2021, outcome "unknown", described as "Slight ear ache"; HYPERTENSION (non-serious), outcome "unknown", described as "blood pressure went sky high". The events "slight ear ache" and "blood pressure went sky high" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Balance test, Blood pressure measurement, Blood test, Circumstance or information capable of leading to medication error
Clinical narrative: blood pressure went sky high; Dizziness; extreme vertigo; Nausea; Unsteadiness; Slight ear ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 (Lot number: EN6203) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "thyroid problem" (unspecified if ongoing), notes: Verbatim: thyroid problem; "lyme disease", start date: 2006 (unspecified if ongoing); "spinal tap" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Rocephin, reaction(s): "very high fever", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date.; Rocephin, reaction(s): "rash all over her body", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date. The following information was reported: DIZZINESS (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Dizziness"; VERTIGO (non-serious) with onset 19Mar2021, outcome "not recovered", described as "extreme vertigo"; NAUSEA (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Nausea"; BALANCE DISORDER (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Unsteadiness"; EAR PAIN (non-serious) with onset 19Mar2021, outcome "unknown", described as "Slight ear ache"; HYPERTENSION (non-serious), outcome "unknown", described as "blood pressure went sky high". The events "slight ear ache" and "blood pressure went sky high" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Ear pain, Electrocardiogram, Hypertension, Magnetic resonance imaging
Clinical narrative: blood pressure went sky high; Dizziness; extreme vertigo; Nausea; Unsteadiness; Slight ear ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 (Lot number: EN6203) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "thyroid problem" (unspecified if ongoing), notes: Verbatim: thyroid problem; "lyme disease", start date: 2006 (unspecified if ongoing); "spinal tap" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Rocephin, reaction(s): "very high fever", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date.; Rocephin, reaction(s): "rash all over her body", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date. The following information was reported: DIZZINESS (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Dizziness"; VERTIGO (non-serious) with onset 19Mar2021, outcome "not recovered", described as "extreme vertigo"; NAUSEA (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Nausea"; BALANCE DISORDER (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Unsteadiness"; EAR PAIN (non-serious) with onset 19Mar2021, outcome "unknown", described as "Slight ear ache"; HYPERTENSION (non-serious), outcome "unknown", described as "blood pressure went sky high". The events "slight ear ache" and "blood pressure went sky high" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Ultrasound Doppler, Ultrasound scan, Vertigo
Clinical narrative: blood pressure went sky high; Dizziness; extreme vertigo; Nausea; Unsteadiness; Slight ear ache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 (Lot number: EN6203) at the age of 81 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "thyroid problem" (unspecified if ongoing), notes: Verbatim: thyroid problem; "lyme disease", start date: 2006 (unspecified if ongoing); "spinal tap" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Rocephin, reaction(s): "very high fever", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date.; Rocephin, reaction(s): "rash all over her body", notes: caller had severe Lyme disease and had a spinal tap. The caller was given Rocephin via a picc line. 2 weeks after starting the Rocephin the caller had a rash all over her body and a very high fever, unknown lot or expiration date. The following information was reported: DIZZINESS (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Dizziness"; VERTIGO (non-serious) with onset 19Mar2021, outcome "not recovered", described as "extreme vertigo"; NAUSEA (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Nausea"; BALANCE DISORDER (non-serious) with onset 19Mar2021, outcome "not recovered", described as "Unsteadiness"; EAR PAIN (non-serious) with onset 19Mar2021, outcome "unknown", described as "Slight ear ache"; HYPERTENSION (non-serious), outcome "unknown", described as "blood pressure went sky high". The events "slight ear ache" and "blood pressure went sky high" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Mucosal disorder, Pain
Clinical narrative: fatigue; feeling  out of it; achy; headache; mucousy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "fatigue"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "feeling  out of it"; PAIN (non-serious) with onset 2021, outcome "unknown", described as "achy"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "headache"; MUCOSAL DISORDER (non-serious) with onset 2021, outcome "unknown", described as "mucousy".  Additional information: Advised given to the patient that she go see her HCP. Patient asked what she should do to make her feel more comfortable, again told her she needs to go see her HCP for this. Due to long hold time.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: experiencing soreness from the first shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 37 years as dose 1 ,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "experiencing soreness from the first shot".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: dizziness; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 56 year-old male patient received bnt162b2 (BNT162B2), administration date 07Apr2021 (Batch/Lot number: unknown) at the age of 56 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset Apr2021, outcome "unknown", described as "dizziness"; HEADACHE (non-serious) with onset Apr2021, outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Feels crummy after CV19 Vax; This is a spontaneous report received from a contactable reporter(s) (Physician).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset 08Apr2021, outcome "unknown", described as "Feels crummy after CV19 Vax".  Additional Information: It was reported as 'Feels crummy after CV19 Vax'. Physician was not having more information it came up during a virtual engagement. Event took place after use of product.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Back pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A 64 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Apr2021 10:00 (Batch/Lot number: unknown) at the age of 64 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PREDNISONE, start date: 09Apr2021 (ongoing); CYCLOBENZAPRINE [CYCLOBENZAPRINE HYDROCHLORIDE], start date: 09Apr2021 (ongoing); TRAMADOL, start date: 09Apr2021 (ongoing). The following information was reported: BACK PAIN (non-serious), outcome "unknown", described as "Back pain". Therapeutic measures were taken as a result of back pain.  Additional information : No additional Vaccines administered on Same Date of the Pfizer Suspect. No Prior Vaccinations (within 4 weeks). The 2nd dose is scheduled for 02May2021. He was currently taking the pain killer, muscle relaxer, and steroid. Vaccination Facility Type: Facility. Reporter clarified that the steroid he was taking was Prednisone 10mg. He started taking it on 09Apr2021. He was still taking it. He was taking it because his back went out. He took three the first day and three the second day. It was that kind of thing. The muscle relaxer was Cyclobenzaprine 10mg. He started it on 09Apr2021 because his back went out and he was still taking it. He takes it once a day before bed. The pain killer was Tramadol 50mg every four hours as needed. He started it on 09Apr2021 because his back went out. He was still taking it. The Prednisone, Cyclobenzaprine, and Tramadol are all in pharmacy bottles, so he doesn't have NDC, lot, and expiry to provide.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.